Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Prolo Pharmaceuticals: Net profit of 891 million yuan in 2025, down 13.62% year-on-year
Pu Luo Pharmaceutical announces that in 2025, operating revenue will be 9.78B yuan, a year-on-year decrease of 18.62%. Net profit is 891 million yuan, a year-on-year decrease of 13.62%. The company’s board of directors has approved the profit distribution plan: based on the company’s total share capital of 1.16B shares minus 30.8123 million shares in the company’s repurchase special securities account, resulting in a share capital of 1.13B shares, a cash dividend of 2.38 yuan (tax included) will be distributed to all shareholders for every 10 shares, with 0 bonus shares (tax included), and no capital increase through reserve funds.